Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment - 06/11/15
Doi : 10.1016/j.jaci.2015.07.034
Ruby F. Fernandez-Boyanapalli, PhD a, Emilia Liana Falcone, MD b, Christa S. Zerbe, MD b, Beatriz E. Marciano, MD b, S. Courtney Frasch, PhD a, Peter M. Henson, DVD, PhD a, Steven M. Holland, MD b, ∗, Donna L. Bratton, MD a, ∗ 
a Department of Pediatrics, National Jewish Health, Denver, Colo
b Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md
| The Chronic Granulomatous Disorder Society (UK) and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant nos. NIH AI110408, HL114381, and AI058228) supported this study. |
|
| Disclosure of potential conflict of interest: P. M. Henson has received grants from the National Institutes of Health (NIH). D. L. Bratton has received grants from the NIH and the Chronic Granulomatous Disorder Society, has received travel support from the NIH, and is employed by National Jewish Health. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2015
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 136 - N° 5
P. 1399 - novembre 2015 Retour au numéro
Article précédent
- Mode of delivery—impact on risk of noncommunicable diseases
- Reetta Miettinen, Henriina Hermansson, Marko Merikukka, Mika Gissler, Erika Isolauri
- Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia
- Elena Crestani, Stefano Volpi, Fabio Candotti, Silvia Giliani, Lucia Dora Notarangelo, Julia Chu, Juan Carlos Aldave Becerra, David Buchbinder, Janet Chou, Raif S. Geha, Maria Kanariou, Alejandra King, Cinzia Mazza, Daniele Moratto, Robert Sokolic, Elizabeth Garabedian, Fulvio Porta, Maria Caterina Putti, Rima H. Wakim, Erdyni Tsitsikov, Sung-Yun Pai, Luigi D. Notarangelo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?